34 studies found for:    Myasthenia Gravis
Show Display Options
Rank Status Study
1 Not yet recruiting A Pilot Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Generalized Myasthenia Gravis
Condition: Myasthenia Gravis
Intervention: Drug: Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
2 Recruiting Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis
Condition: Myasthenia Gravis
Intervention: Biological: Hematopoietic Stem Cell Transplantation
3 Active, not recruiting The Role of the Thymus in Myasthenia Gravis
Conditions: Myasthenia Gravis;   Thymoma
Intervention:
4 Active, not recruiting Efficacy of Methotrexate in Myasthenia Gravis
Condition: Myasthenia Gravis
Interventions: Drug: Methotrexate;   Other: Placebo
5 Recruiting Subcutaneous Ig Maintenance Therapy for Myasthenia Gravis
Condition: Myasthenia Gravis
Intervention: Drug: Subcutaneous immunoglobulins
6 Completed Intravenous Immune Globulin Treatment Compared to Placebo in Patients With Myasthenia Gravis
Condition: Myasthenia Gravis
Intervention: Drug: Intravenous ImmuneGlobulin
7 Active, not recruiting Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy
Condition: Myasthenia Gravis
Interventions: Procedure: thymectomy;   Drug: prednisone
8 Completed Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis
Condition: Myasthenia Gravis
Interventions: Drug: eculizumab;   Drug: Placebo
9 Recruiting A Study to Compare the Efficacy and Safety of Tacrolimus Capsules in Patient With Myasthenia Gravis
Condition: Myasthenia Gravis
Interventions: Drug: Tacrolimus capsule;   Drug: Placebo
10 Completed A Pilot Trial of Rituxan in Refractory Myasthenia Gravis
Condition: Refractory Myasthenia Gravis
Intervention: Drug: Rituximab (Rituxan)
11 Completed Efficacy and Safety Study of GB-0998 for Treatment of Generalized Myasthenia Gravis
Condition: Generalized Myasthenia Gravis
Interventions: Biological: GB-0998 (Intravenous immunoglobulin);   Procedure: Plasmapheresis
12 Recruiting Study Comparing Two Tapering Strategies of Prednisone in Myasthenia Gravis
Condition: Myasthenia Gravis
Intervention: Drug: Prednisone - Azathioprine
13 Unknown  Trial of Mycophenolic Acid Versus Azathioprine in the Treatment of Corticosteroid-refractory Myasthenia Gravis
Condition: Myasthenia Gravis
Interventions: Drug: Mycophenolic acid;   Drug: AZA
14 Completed Mycophenolate Mofetil in Myasthenia Gravis
Condition: Myasthenia Gravis
Intervention: Drug: mycophenolate mofetil
15 Recruiting Exercise for Stable Myasthenia Gravis
Condition: Myasthenia Gravis
Intervention: Other: Exercise
16 Completed Intravenous Immunoglobulin and Plasma Exchange in Myasthenia Gravis
Condition: Myasthenia Gravid
Interventions: Biological: IVIG;   Procedure: PLEX
17 Completed Rituximab for the Treatment of Refractory Inflammatory Myopathies and Refractory Myasthenia Gravis
Conditions: Myositis;   Myasthenia Gravis
Intervention: Drug: Rituximab
18 Recruiting The Evaluation of Belimumab in Myasthenia Gravis (MG)
Condition: Myasthaenia Gravis
Interventions: Biological: Belimumab;   Other: Placebo
19 Completed FK506 Phase 3 Study: a Study for Steroid Non-Resistant Myasthenia Gravis (MG) Patients
Condition: Myasthenia Gravis
Interventions: Drug: tacrolimus;   Drug: placebo
20 Terminated Pharmacodynamic Study of CK-2017357 in Patients With Generalized Myasthenia Gravis
Condition: Myasthenia Gravis
Interventions: Drug: Placebo;   Drug: 250 mg CK-2017357;   Drug: 500 mg CK-2017357

Previous Page Studies Shown (1-20) Next Page (21-34) Show next page of results
Indicates status has not been verified in more than two years